Prioritizing Innovation To Get Ahead Of The Market

How successful you are at innovating and bringing therapeutics to market directly impacts the growth and financial prospects of your business. Drug approval rates are a key measure of this success and when shareholders consider compound annual growth rates, they are directly considering the ability of your research and development (R&D) teams to continue to develop novel products. Drug development companies must prioritize R&D to maintain a competitive advantage, and yet organizations are restraining the very teams that are needed to drive this ground-breaking work, with half of respondents required to check inventory at least once per week.

How can you better manage routine administration tasks that steal 40% of your team's valuable time? Explore the conflict that exists between necessary administration tasks and innovation. Additionally, learn how digital laboratory productivity technology can liberate scientists, enabling organizations to prioritize innovation for competitive advantage.